Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight ...

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...

It was the first head-to-head comparison of the injectable GLP-1 medications semaglutide and tirzepatide, which are sold under the brand names Wegovy and Zepbound for weight loss. Roughly 750 ...

Women taking weight-loss jabs have been warned to use contraceptives or risk having unplanned ‘Ozempic babies’.

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs receive a prescription for it, according to a new study from Yale School of Medicine. Yuan Lu, co-author of ...